Categories Analysis, Health Care, IPO

SmileDirectClub stock hits its lowest since IPO amid analyst initiations

SmileDirectClub (NASDAQ: SDC) stock has fallen 32% to $11.20 on Tuesday, which is the teledentistry company’s lowest since the initial public offering on September 12. Investors remained concerned about the company’s growth prospects despite the “buy” equivalent-rating given by all of the ten banks that led its IPO.

The firms believed an outstanding and robust future for the teeth-straightening startup. The company is expected to turn beneficial in the future driven by the convenience and ease of access over the traditional orthodontics business model. The company’s new business model has grown rapidly backed by the demand for the product, despite facing significant challenges from regulators and potential competitors.

However, the company has been struggling to manage the complaints filed against it in the last five years. The complaints raised questions about its practice of medicine and the lives of patients while the dental boards in Georgia and Alabama have deemed certain of its practices as illegal.

SmileDirectClub stock hits lowest since IPO
Courtesy: SmileDirectClub / Facebook post

The company has incurred net operating losses since inception and this is likely to continue in the near future. Till now, significant funds were spent in organizational and start-up activities, to recruit employees, to develop clear aligners, to develop manufacturing and member support resources, and for research and development.

The adoption of the teledentistry model by the consumers remained the main of the company. The unwillingness of adoption by the consumers could hurt the company’s future results. However, the company expects sales of its clear aligners to continue to account for the vast majority of its total net revenues for the foreseeable future.

Read: Spotify looks bumpy in the road to growth

The total market of SmileDirectClub is greater than 120 million people in the US and about 500 million people globally, based on total malocclusion prevalence and age and income demographics. The company is in the early stage of penetrating the opportunity of addressing over 90% of the market today.

Also Read:  Avid Bioservices, Inc. (CDMO) Q1 2021 Earnings Call Transcript

For the six months ended June 30, 2019, the company reported a 113% jump in revenues as an increase in the number of website visitors and conversion thereof to aligner sales drove unique aligner orders higher. An increase in the costs and expenses specifically of sales and marketing spend hurt the bottom line with the loss expanding wider than the prior-year period.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

COVID-19 drove retailers up the digital path years ahead than anticipated

Earlier we looked into how, during the COVID-19 pandemic, retailers saw changing trends in terms of their assortments and how the acceleration of online shopping led many of them to

Snowflake (SNOW) creates a record as the most successful software IPO ever; stock more than doubles

Data is at the heart of business innovation. Recognizing this trend, companies are seeking ways to transform their businesses by capturing, analyzing, and mobilizing data. The public cloud is becoming

Adobe (ADBE) sees new tailwinds as virtual shift gathers steam

The second half has been highly rewarding for design software maker Adobe Inc. (NASDAQ: ADBE) amid stable demand for digital content solutions. The company has remained unaffected by the virus-related